Results 221 to 230 of about 1,771,429 (303)

On the impact of mass screening for SARS-CoV-2 through self-testing in Greece. [PDF]

Front Public Health
Gilmour S, Sapounas S, Drakopoulos K, Jaillet P, Magiorkinis G, Trichakis N.   +5 more
europepmc   +1 more source

Saliva-based COVID-19 Rapid Antigen Test: a practical and accurate alternative mass screening method

, 2022
Diawara I, Ahid S, Jeddane L, Kim S, Nejjari C.   +4 more
europepmc   +1 more source

Multi-residue screening method of acidic pesticides in agricultural products by liquid chromatography/time of flight mass spectrometry

, 2009
Yumi Akiyama, Tomofumi Matsuoka, Takao Mitsuhashi   +2 more
openalex   +2 more sources

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Cystic renal mass screening: machine-learning-based radiomics on unenhanced computed tomography [PDF]

Diagn Interv Radiol
Huang L, Ye Y, Chen J, Feng W, Peng S, Du X, Li X, Song Z, Liu T.   +8 more
europepmc   +1 more source

Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons. [PDF]

Clin Infect Dis, 2021
Santos ADS, de Oliveira RD, Lemos EF, Lima F, Cohen T, Cords O, Martinez L, Gonçalves C, Ko A, Andrews JR, Croda J.   +10 more
europepmc   +1 more source

Retrospective study of sputum cytology in primary adenocarcinoma of the lung detected by chest X-ray film in population-based mass screening.

, 1998
Maya SASAKI, Ryutaro Nakashima, Sigeko NAKAMURA, Sumiko YAMAZAKI, H. Sato, S Sato, Masami Sato, Sigefumi Fujimura, Keiji Kanma, Yasuki Saito   +9 more
openalex   +2 more sources

A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening [PDF]

, 2015
Tim J. Wigle, Kerren K. Swinger, John E. Campbell, Michael D. Scholle, John Sherrill, Elizabeth A. Admirand, P. Ann Boriack‐Sjodin, Kevin W. Kuntz, Richard Chesworth, Mikel P. Moyer, Margaret Porter Scott, Robert A. Copeland   +11 more
openalex   +1 more source

Additional file 5 of The NORMAN Suspect List Exchange (NORMAN-SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry

, 2022
Hiba Mohammed Taha, Reza Aalizadeh, ‪Nikiforos Alygizakis, Jean‐Philippe Antignac, Hans Peter H. Arp, Richard Bade, Nancy Baker, Lidia Belova, Lubertus Bijlsma, Evan Bolton, Werner Brack, Alberto Celma, Wen‐Ling Chen, Tiejun Cheng, Parviel Chirsir, Ľuboš Čirka, Lisa A. D’Agostino, Yannick Djoumbou-Feunang, Valeria Dulio, Stellan Fischer, Pablo Gago-Ferrero, Aikaterini Galani, Birgit Geueke, Natalia Głowacka, Juliane Glüge, Ksenia J. Groh, Sylvia Grosse, Peter Haglund, Pertti J. Hakkinen, Sarah E. Hale, Félix Hernández, Elisabeth M.‐L. Janssen, Tim Jonkers, Karin Kiefer, Michal Kirchner, Jan Koschorreck, Martin Krauß, Jessy Krier, M.H. Lamoree, Marion Letzel, Thomas Letzel, Qingliang Li, James J. Little, Yanna Liu, David M. Lunderberg, Jonathan W. Martin, Andrew D. McEachran, John A. McLean, Christiane Meier, Jeroen Meijer, Frank Menger, Carla Merino, Jane Muncke, Matthias Muschket, Michael Neumann, Vanessa Neveu, Kelsey Ng, Herbert Oberacher, Jake O’Brien, Peter Oswald, Martina Oswaldova, Jaqueline A. Picache, Cristina Postigo, Noelia Ramírez, Thorsten Reemtsma, Justin B. Renaud, Paweł Rostkowski, Heinz Rüdel, Reza M. Salek, Saer Samanipour, Martin Scheringer, Ivo Schliebner, W. Schulz, Tobias Schulze, Manfred Sengl, Benjamin A. Shoemaker, Kerry Sims, Heinz Singer, Randolph R. Singh, Mark W. Sumarah, Paul Thiessen, Kevin V. Thomas, Sònia Torres, Xenia Trier, Annemarie P. van Wezel, Roel Vermeulen, Jelle Vlaanderen, Peter C. von der Ohe, Zhanyun Wang, Antony Williams, Egon Willighagen, David S. Wishart, Jian Zhang, Νikolaos S. Τhomaidis, Juliane Hollender, Jaroslav Slobodnı́k, Emma Schymanski   +96 more
openalex   +1 more source

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez   +18 more
wiley   +1 more source